This article is brought to you by SpecialChem.

Pamela Busiek, President & CEO, ICMAD; Steve Sleeper, Executive Director, PBA And LEZLEE WESTINE, President & CEO, PCC comment on the Safe Cosmetics and Personal Care Products Act of 2013 (H.R.1385) Introduced in Congress by Representatives Jan Schakowsky (D-IL) and Edward Markey (D-MA).

They commented, “While we agree with Representatives Schakowsky and Markey that certain provisions of the Food, Drug and Cosmetic (FD&C) Act should be modernized to keep pace with evolving science and the growth of the personal care industry, we believe our industry’s approach as outlined below is practical and science-based. We are working with Members of Congress and the Food and Drug Administration (FDA) to propose changes to the law that will make meaningful enhancements to cosmetics regulation without overburdening FDA or imposing costly and unnecessary restrictions on American businesses.”

The safety of cosmetic and personal care products in the U.S. is overseen by FDA under the FD&C Act. The law requires that all cosmetics be substantiated for safety before they are marketed, contain no prohibited ingredients, and that all labeling and packaging must be in compliance with U.S. regulations. Under the FD&C Act, it is a federal crime to market an unsafe cosmetic product.

“Our goal is that an agreement on cosmetics legislation will be reached quickly with FDA and that legislation that enhances FDA’s regulatory authority can be passed on a bipartisan basis.

For more information, the full article and a list of recommendations provided by ICMAD, PBA & PCPC please refer to the SpecialChem link above.